Vascular remodeling process in pulmonary arterial hypertension, with focus on miR-204 and miR-126 (2013 Grover Conference series).
about
MicroRNAs and Endothelial (Dys) FunctionRight ventricular ST-elevation myocardial infarction as a cause of death in idiopathic pulmonary arterial hypertension.Syngeneic cardiac and bone marrow stromal cells display tissue-specific microRNA signatures and microRNA subsets restricted to diverse differentiation processesAge- and glycemia-related miR-126-3p levels in plasma and endothelial cells.microRNAs Distinctively Regulate Vascular Smooth Muscle and Endothelial Cells: Functional Implications in Angiogenesis, Atherosclerosis, and In-Stent Restenosis.MicroRNAs in pulmonary arterial hypertension.Role of miR206 in genistein-induced rescue of pulmonary hypertension in monocrotaline model.Dual targeting of ANGPT1 and TGFBR2 genes by miR-204 controls angiogenesis in breast cancer.MicroRNAs in heart failure: Non-coding regulators of metabolic function.microRNA and Pulmonary Hypertension.Critical effects of epigenetic regulation in pulmonary arterial hypertension.Molecular mechanisms in vascular injury induced by hypertension: Expression and role of microRNA-34a.MicroRNA-145-targeted drug and its preventive effect on pulmonary arterial hypertension (patent WO2012153135 A1).Translational Advances in the Field of Pulmonary Hypertension. Translating MicroRNA Biology in Pulmonary Hypertension. It Will Take More Than "miR" Words.Overexpression of microRNA-506-3p aggravates the injury of vascular endothelial cells in patients with hypertension by downregulating Beclin1 expression.MiR-126a-5p is involved in the hypoxia-induced endothelial-to-mesenchymal transition of neonatal pulmonary hypertension.miR-223-IGF-IR signalling in hypoxia- and load-induced right-ventricular failure: a novel therapeutic approach.
P2860
Q26775547-A050F2C9-30DE-48CE-9C40-89D2D3047FA3Q33788521-BC0397AC-7B82-4CAF-9D76-74E25E584FDAQ34215130-72998A1A-0F86-4867-AA68-5BEAB8E5692CQ34461150-EC1AE63D-2BBB-412C-845C-177CBF6DED11Q34504964-5BE6EF70-645A-4E45-8D6C-90DE92CA020DQ35207669-92016E9D-D6B0-4820-8314-E991E24978A3Q36382227-92AD26AB-793A-4FB2-8B4F-F923FA06B10BQ37310788-041F75CC-DB0E-4AE9-84B2-F3A777D781D7Q37733659-AA330E7F-751D-45F0-B199-EC44A1E3E1DEQ38668258-801A7760-BFEF-4054-9EAC-F2C8993D4584Q39345470-F42AB87F-785E-46CC-A8B5-9EC3DE16A4B6Q47236889-8102DD64-64AB-4AC8-8CBF-C56AA30CE17AQ48045287-99131E16-DAC6-4819-BEA4-2E5AA71FD0ACQ49312062-14A79339-6853-42B8-BD2F-BC77BE4FE2D6Q49875499-3D1C5DBB-DD5D-4FE7-A60B-EEF053BCA53CQ55004780-D183BD44-8539-4E60-B820-C0A6756A11DEQ55026266-57757DB6-EB75-478C-B534-FD734AB6D3BE
P2860
Vascular remodeling process in pulmonary arterial hypertension, with focus on miR-204 and miR-126 (2013 Grover Conference series).
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Vascular remodeling process in ...... 013 Grover Conference series).
@en
type
label
Vascular remodeling process in ...... 013 Grover Conference series).
@en
prefLabel
Vascular remodeling process in ...... 013 Grover Conference series).
@en
P2093
P2860
P356
P1476
Vascular remodeling process in ...... 013 Grover Conference series).
@en
P2093
Colin Graydon
François Potus
Steeve Provencher
Sébastien Bonnet
P2860
P304
P356
10.1086/675980
P577
2014-06-01T00:00:00Z